Adverse Pregnancy Outcomes Associated with Dermatologic Medications: A Cross-Sectional Study of U.S. Food and Drug Administration Reports
Published: 15 September 2025| Version 2 | DOI: 10.17632/fnf4t4x2dz.2
Contributor:
Ghida EL BannaDescription
This supplementary data include list of 121 medications included in this study (Table 1), list of reaction terms analyzed (Table 2), and a detailed list of all adverse outcomes (type and frequencies) organized by medication groups and individual medications (Table 3 -11).
Files
Steps to reproduce
Please see methods section in the article.
Institutions
- Massachusetts General HospitalMA, Boston
Categories
Congenital Anomaly, Abortion, Miscarriage, General Dermatology, Drug Safety, Pharmacovigilance